Here’s a turnabout for the books.
Most of the time we see market research showing how consumers are concerned about a range of pharmaceutical industry issues (from access to drug prices to salaries of CEOs). This weekend we saw something rather different! Data from a survey published by the Association of the British Pharmaceutical Industry (ABPI) and [...]
Filed under: Drug development / clinical trials, Health and drug costs, health economics | Tagged: pharmaceuticals UK pricing R&D | Comments Off
